✨ Free AI Report
Abogen, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Abogen, Inc.
Company Research

Abogen, Inc.: Business Overview, Financials & Competitive Analysis

Abogen, Inc. scores 4/10 on the AskCyborg Cyborg Score (Mixed). Pre-commercial biotech with validated IP but uncertain path to commercial scale and profitability. The company has proven core technology and early market validation through research partnerships, but faces challenges with minimal scale (2-10 employees), very limited funding history (~$1.3M to $1.6M raised), and stalled fundraising momentum since 2017. No recent.

What is Abogen, Inc.'s industry? Abogen, Inc. (abogen.com) operates in In-Vitro Diagnostics. AskCyborg classifies Abogen, Inc. under In-Vitro Diagnostics in its company registry.

Abogen, Inc. is a Portland-based biotechnology company that develops non-invasive diagnostic technologies using saliva as an alternative to blood samples. Founded in 2012, the company has pioneered technology that ena...

4/ 10Mixed

Cyborg Score thesis

Pre-commercial biotech with validated IP but uncertain path to commercial scale and...

Read the full analyst-debate transcript →
Industry In-Vitro Diagnostics
5 named competitors
2 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 12, 2026
AI-Verified Research
30+ Page Report

Get the Latest Abogen, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Abogen, Inc.

AskCyborg analysts argue the bull and bear cases for Abogen, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Abogen, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Abogen, Inc. Overview

Pro stress-test →

Abogen, Inc. is a Portland-based biotechnology company that develops non-invasive diagnostic technologies using saliva as an alternative to blood samples. Founded in 2012, the company has pioneered technology that enables cell-based research and diagnostics through saliva extraction, potentially replacing up to 80% of the five billion annual invasive blood draws.

Strategic Profile

Pro stress-test →

Abogen positions itself as the world's first validated provider of saliva-based diagnostics for research and laboratory applications. The company's competitive advantage lies in its proprietary technology platform and third-party validated results, targeting the massive diagnostic sampling market with a less invasive, more patient-friendly approach.

Competitive Landscape

Pro stress-test →

Direct competitors in non-invasive diagnostics are limited, but Abogen competes indirectly against traditional phlebotomy services, at-home blood testing kits (e.g., Theranos predecessors, Quest Diagnostics, LabCorp), and alternative sampling platforms. The saliva-diagnostics space is nascent with few established players.

Industry Context

Abogen, Inc. operates in In-Vitro Diagnostics.

Key facts

Founded: 2012 · Headquarters: Portland, Maine, US · Employees: 2-10 · Revenue: $1.5M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Abogen, Inc..

  • Pioneered saliva-based diagnostic extraction validated by independent third parties, addressing patient comfort and safety in clinical sampling
  • Minimal capitalization and employee count suggest nascent stage with bootstrap or angel-dependent funding model
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • 2017Seeking Series A funding of $4M according to SEC filing (July 2017)
  • 2013-2017Accumulated approximately $1.3M-$1.6M in seed funding from Maine Angels and state grants
Get alerted when Abogen, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

At-home blood testingLeading clinical laboratory services and at-home test kits→OralDNA LabsSalivary diagnostics for healthcare providers specializing in oral health testing→SalignosticsSaliva-based diagnostics platform with pregnancy testing, biomarker detection, and point-of-care solutions→OrisDXSaliva-based molecular diagnostics for early detection of oral and head-neck cancers→Oasis DiagnosticsNon-invasive saliva-based collection and rapid point-of-care diagnostic testing platform→

Compare Abogen, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Abogen, Inc. operates in In-Vitro Diagnostics. See how the rest of the sector scores on the Cyborg framework.

Browse In-Vitro Diagnostics research →
NEW · MCP server

Ask your AI assistant about Abogen, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Abogen, Inc. and its top competitor on Cyborg Score”
“What did Abogen, Inc. do this quarter?”
“Is Abogen, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Abogen, Inc. do?+
Abogen, Inc. is a Portland-based biotechnology company that develops non-invasive diagnostic technologies using saliva as an alternative to blood samples. Founded in 2012, the company has pioneered technology that ena...
What is Abogen, Inc.'s Cyborg Score?+
Abogen, Inc. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Abogen, Inc.'s main competitors?+
Named competitors include At-home blood testing, OralDNA Labs, Salignostics, OrisDX. The full competitive landscape is in the AskCyborg report.
How can I get the full Abogen, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Abogen, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Abogen, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More In-Vitro Diagnostics research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7DiaSorin S.p.A.7Shenzhen New Industries Biomedical Engineering Co., Ltd.4Biosynex SA